Cargando…
Brain Tumor Immunotherapy: What have We Learned so Far?
High grade glioma is a rare brain cancer, incurable in spite of modern neurosurgery, radiotherapy, and chemotherapy. Novel approaches are in research, and immunotherapy emerges as a promising strategy. Clinical experiences with active specific immunotherapy demonstrate feasibility, safety and most i...
Autor principal: | Van Gool, Stefaan Willy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470276/ https://www.ncbi.nlm.nih.gov/pubmed/26137448 http://dx.doi.org/10.3389/fonc.2015.00098 |
Ejemplares similares
-
MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021) -
Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020) -
Cancer Chemoprevention: Classic and Epigenetic Mechanisms Inhibiting Tumorigenesis. What Have We Learned So Far?
por: de Melo, Fabiana Henriques Machado, et al.
Publicado: (2018) -
COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020) -
The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)